clinical trials

News

Roche takes new antibiotic into phase 3 for 'urgent threat'

Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance.

News

ASCO 25: Roche places Itovebi marker in breast cancer

Roche's Itovebi has become the first PI3K inhibitor to extend survival in HR-positive, HER2-negative breast cancer with a PIK3CA mutation.

News

US imposes limits on COVID-19 boosters and new jabs

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

News

Beckley Psytech's chief scientific and medical officer Dr Rob Conley

Beckley's psychedelic med inches forward in depression

UK psychedelic medicines developer Beckley Psytech has said its candidate for treatment-resistant depression has enhanced the effect of standard antidepressants in a phase 2 trial.

News

O'Shaughnessy says UK clinical trials sector is on the mend

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead."

News

Imec showcases ingestible sensor for gut studies

Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.

Roche takes new antibiotic into phase 3 for 'urgent threat'

ASCO 25: Roche places Itovebi marker in breast cancer

US imposes limits on COVID-19 boosters and new jabs

Beckley's psychedelic med inches forward in depression

O'Shaughnessy says UK clinical trials sector is on the mend

Imec showcases ingestible sensor for gut studies

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks